Carvedilol (CAS 72956-09-3), C24H26N2O4, the formula weight is 406.47, and its form is white to off-white solid.
Carvedilol is indicated for symptomatic heart failure and for essential hypertension.

Market Analysis and Insights: Global and Japan Carvedilol Market
This report focuses on global and Japan Carvedilol market.
In 2020, the global Carvedilol market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Carvedilol market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Carvedilol Scope and Market Size
Carvedilol market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Carvedilol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Carvedilol market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Tablet
Capsule

Segment by Application
Primary Hypertension
Congestive Heart Failure (CHF)
Left Ventricular Dysfunction
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Qilu Pharmaceutical
Roche
Cipla
Ningbo Tianheng Pharmaceutical
Apotex INC
Aurobindo Pharma
BEXIMCO USA
Teva
Mylan
TARO
Sun Pharminds
Zydus Pharms
Lupin
Sandoz
Glenmark Generics
DR Reddy's Labs
Chartwell Molecular